• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

高 VWF、低 ADAMTS13 和口服避孕药会增加年轻女性发生缺血性卒中和心肌梗死的风险。

High VWF, low ADAMTS13, and oral contraceptives increase the risk of ischemic stroke and myocardial infarction in young women.

机构信息

Centre for Haematology, Faculty of Medicine, Imperial College London, London, United Kingdom.

出版信息

Blood. 2012 Feb 9;119(6):1555-60. doi: 10.1182/blood-2011-09-380618. Epub 2011 Nov 22.

DOI:10.1182/blood-2011-09-380618
PMID:22110247
Abstract

VWF and ADAMTS13 are major determinants of platelet adhesion after vessel injury. In the present study, we aimed to determine whether VWF or ADAMTS13 plasma antigen levels influence the risks of ischemic stroke (IS) or myocardial infarction (MI) in young women and how these risks are affected by oral contraceptive (OC) use. VWF and ADAMTS13 plasma antigen levels were measured in a frequency-matched case-control study of 1018 young (18-49 years) women including 175 IS patients and 205 MI patients. Increasing levels of VWF and decreasing levels of ADAMTS13 were associated with the risk of IS and MI in a dose-dependent manner. Having both high VWF and low ADAMTS13 resulted in an odds ratio (OR) of 6.9 (95% confidence interval [95% CI], 2.0-23.0) for IS and 11.3 (95% CI, 3.6-35.2) for MI. Use of OCs increased the risk of IS and MI associated with high VWF (OR = 12; 95% CI, 5.5-26.2 and OR = 7.5, 95% CI, 3.6-15.7, respectively) and the risk of IS associated with low ADAMTS13 (OR = 5.8, 95% CI, 2.7-12.4). We conclude that high VWF and low ADAMTS13 plasma levels both increase the risk of IS and MI. The risks associated with high VWF or low ADAMTS13 levels are further increased by the use of OCs.

摘要

血管性血友病因子(VWF)和血管性血友病因子裂解蛋白酶(ADAMTS13)是血管损伤后血小板黏附的主要决定因素。在本研究中,我们旨在确定 VWF 或 ADAMTS13 血浆抗原水平是否影响年轻女性发生缺血性卒中(IS)或心肌梗死(MI)的风险,以及这些风险如何受到口服避孕药(OC)使用的影响。在一项频率匹配的病例对照研究中,我们测量了 1018 名年轻(18-49 岁)女性(包括 175 名 IS 患者和 205 名 MI 患者)的 VWF 和 ADAMTS13 血浆抗原水平。VWF 水平升高和 ADAMTS13 水平降低与 IS 和 MI 的风险呈剂量依赖性相关。同时存在高 VWF 和低 ADAMTS13 会导致 IS 的比值比(OR)为 6.9(95%置信区间[95%CI],2.0-23.0),MI 的 OR 为 11.3(95%CI,3.6-35.2)。OC 的使用增加了与高 VWF(OR=12;95%CI,5.5-26.2 和 OR=7.5,95%CI,3.6-15.7)相关的 IS 和 MI 风险,以及与低 ADAMTS13(OR=5.8,95%CI,2.7-12.4)相关的 IS 风险。我们得出结论,高 VWF 和低 ADAMTS13 血浆水平均增加 IS 和 MI 的风险。OC 的使用进一步增加了与高 VWF 或低 ADAMTS13 水平相关的风险。

相似文献

1
High VWF, low ADAMTS13, and oral contraceptives increase the risk of ischemic stroke and myocardial infarction in young women.高 VWF、低 ADAMTS13 和口服避孕药会增加年轻女性发生缺血性卒中和心肌梗死的风险。
Blood. 2012 Feb 9;119(6):1555-60. doi: 10.1182/blood-2011-09-380618. Epub 2011 Nov 22.
2
ADAMTS13 and von Willebrand factor and the risk of myocardial infarction in men.ADAMTS13、血管性血友病因子与男性心肌梗死风险
Blood. 2007 Mar 1;109(5):1998-2000. doi: 10.1182/blood-2006-07-038166. Epub 2006 Oct 19.
3
High von Willebrand factor levels increase the risk of first ischemic stroke: influence of ADAMTS13, inflammation, and genetic variability.高血管性血友病因子水平会增加首次缺血性中风的风险:ADAMTS13、炎症及基因变异性的影响。
Stroke. 2006 Nov;37(11):2672-7. doi: 10.1161/01.STR.0000244767.39962.f7. Epub 2006 Sep 21.
4
Lower levels of ADAMTS13 are associated with cardiovascular disease in young patients.ADAMTS13 水平降低与年轻患者的心血管疾病相关。
Atherosclerosis. 2009 Nov;207(1):250-4. doi: 10.1016/j.atherosclerosis.2009.04.013. Epub 2009 Apr 17.
5
Acute myocardial infarction as a systemic prothrombotic condition evidenced by increased von Willebrand factor protein over ADAMTS13 activity in coronary and systemic circulation.急性心肌梗死作为一种全身性血栓形成前状态,表现为在冠状动脉和体循环中血管性血友病因子蛋白水平升高超过ADAMTS13活性。
Heart Vessels. 2008 Sep;23(5):301-7. doi: 10.1007/s00380-008-1053-x. Epub 2008 Sep 20.
6
Serial changes in von Willebrand factor-cleaving protease (ADAMTS13) and prognosis after acute myocardial infarction.急性心肌梗死后血管性血友病因子裂解蛋白酶(ADAMTS13)的系列变化与预后
Am J Cardiol. 2007 Sep 1;100(5):758-63. doi: 10.1016/j.amjcard.2007.03.095. Epub 2007 Jun 12.
7
Plasma levels of active Von Willebrand factor are increased in patients with first ST-segment elevation myocardial infarction: a multicenter and multiethnic study.首次ST段抬高型心肌梗死患者血浆活性血管性血友病因子水平升高:一项多中心多民族研究
Eur Heart J Acute Cardiovasc Care. 2015 Feb;4(1):64-74. doi: 10.1177/2048872614534388. Epub 2014 May 15.
8
Assessment of the Diagnostic Value of Plasma Levels, Activities, and Their Ratios of von Willebrand Factor and ADAMTS13 in Patients with Cerebral Infarction.评估血浆血管性血友病因子和ADAMTS13水平、活性及其比值在脑梗死患者中的诊断价值。
Clin Appl Thromb Hemost. 2016 Apr;22(3):252-9. doi: 10.1177/1076029615583347. Epub 2015 Apr 27.
9
[Determination of ADAMTS13 antigen and activity levels in patients with acute myocardial infarction and acute ischemic stroke].[急性心肌梗死和急性缺血性脑卒中患者中ADAMTS13抗原及活性水平的测定]
Zhonghua Xue Ye Xue Za Zhi. 2008 Mar;29(3):161-3.
10
Relationship between ADAMTS13 activity, von Willebrand factor antigen levels and platelet function in the early and late phases after TIA or ischaemic stroke.短暂性脑缺血发作(TIA)或缺血性卒中后早期和晚期ADAMTS13活性、血管性血友病因子抗原水平与血小板功能之间的关系。
J Neurol Sci. 2015 Jan 15;348(1-2):35-40. doi: 10.1016/j.jns.2014.10.035. Epub 2014 Oct 31.

引用本文的文献

1
The von Willebrand factor/ADAMTS13 ratio as an indicator of venous thromboembolism risk: results from the RETROVE project.血管性血友病因子/ADAMTS13 比值作为静脉血栓栓塞风险指标:RETROVE 项目的结果
J Thromb Thrombolysis. 2025 Aug 14. doi: 10.1007/s11239-025-03165-4.
2
The Role of the VWF/ADAMTS13 Axis in the Thromboinflammatory Response in Ischemic Stroke After SARS-CoV2 Infection.血管性血友病因子/凝血酶原酶-13轴在SARS-CoV2感染后缺血性卒中血栓炎症反应中的作用
Brain Behav. 2025 Feb;15(2):e70348. doi: 10.1002/brb3.70348.
3
Arginine Methylation by PRMT1 Affects ADAMTS13 Secretion and Enzymatic Activity.
PRMT1介导的精氨酸甲基化影响ADAMTS13的分泌及酶活性。
Arterioscler Thromb Vasc Biol. 2025 Apr;45(4):506-522. doi: 10.1161/ATVBAHA.124.322249. Epub 2025 Feb 13.
4
Relationship Between Intraluminal Thrombus Volume and Circulating ADAMTS-13 Activity in Abdominal Aortic Aneurysms.腹主动脉瘤腔内血栓体积与循环中ADAMTS-13活性之间的关系
EJVES Vasc Forum. 2024 Jul 31;62:41-45. doi: 10.1016/j.ejvsvf.2024.07.040. eCollection 2024.
5
Dynamic Assessment of Plasma von Willebrand Factor and ADAMTS13 Predicts Mortality in Hospitalized Patients with SARS-CoV-2 Infection.血浆血管性血友病因子和含血小板解聚蛋白及金属蛋白酶13的动态评估可预测新型冠状病毒肺炎住院患者的死亡率
J Clin Med. 2023 Nov 19;12(22):7174. doi: 10.3390/jcm12227174.
6
Coagulation factor VIII regulates von Willebrand factor homeostasis invivo.凝血因子 VIII 在体内调节血管性血友病因子的稳态。
J Thromb Haemost. 2023 Dec;21(12):3477-3489. doi: 10.1016/j.jtha.2023.09.004. Epub 2023 Sep 17.
7
A novel mechanism underlying allosteric regulation of ADAMTS-13 revealed by hydrogen-deuterium exchange plus mass spectrometry.氢氘交换质谱法揭示的ADAMTS-13变构调节潜在新机制
Res Pract Thromb Haemost. 2022 Dec 13;7(1):100012. doi: 10.1016/j.rpth.2022.100012. eCollection 2023 Jan.
8
The Role of the Coagulation System in Peripheral Arterial Disease: Interactions with the Arterial Wall and Its Vascular Microenvironment and Implications for Rational Therapies.凝血系统在外周动脉疾病中的作用:与动脉壁及其血管微环境的相互作用以及对合理治疗的影响。
Int J Mol Sci. 2022 Nov 29;23(23):14914. doi: 10.3390/ijms232314914.
9
Genetic Variation in ADAMTS13 is Related to VWF Levels, Atrial Fibrillation and Cerebral Ischemic Events.ADAMTS13 基因变异与 vWF 水平、心房颤动和脑缺血事件有关。
Clin Appl Thromb Hemost. 2022 Jan-Dec;28:10760296221141893. doi: 10.1177/10760296221141893.
10
Changes in Plasma Levels of ADAMTS13 and von Willebrand Factor in Patients Undergoing Elective Joint Arthroplasty.择期关节置换术患者血浆中ADAMTS13和血管性血友病因子水平的变化
J Clin Med. 2022 Oct 30;11(21):6436. doi: 10.3390/jcm11216436.